AKRO Akero Therapeutics, Inc.: institutional ownership and insider trading
6 funds reported holding $9.42M of Akero Therapeutics, Inc. in their latest 13F filings; in Q1 2026 funds net bought $0, with 0 new positions and 2 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of AKRO
- Nuveen Asset Management, LLC — $4.77M
- AXA Investment Managers S.A. — $3.38M
- WOLVERINE TRADING, LLC — $1.03M
- Point72 (DIFC) Ltd — $175K
- Lindbrook Capital, LLC — $65.1K
- Hemington Wealth Management — $0
Recent AKRO insider trades
- Oct 10, 2025: Cheng Andrew sold 30,000 shares ($1.62M)
- Oct 7, 2025: Rolph Timothy sold 12,500 shares ($576K)
- Oct 1, 2025: Young Jonathan sold 12,500 shares ($597K)
- Sep 11, 2025: Cheng Andrew sold 31,796 shares ($1.37M)
5%+ owners
- General Atlantic, L.P.: 8.4% (Schedule 13G/A, filed May 15, 2025)